Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Brain Cancer Vaccine Extends Survival

October 5, 2010 7:24 am | News | Comments

A new vaccine added to standard therapy appears to offer a survival advantage for patients suffering from glioblastoma, the most deadly form of brain cancer. The vaccine knocks out a growth factor that characterizes the most aggressive form of the disease.

TOPICS:

Norian Paying Maximum Fine for Unapproved Trials

October 5, 2010 7:09 am | by Maryclaire Dale | News | Comments

A Pennsylvania medical devices company will pay the maximum $23 million fine for illegally testing bone cement on about 200 spinal patients, three of whom died during surgery.

TOPICS:

Tris Pharma Marketing Generic Tussionex

October 5, 2010 7:05 am | News | Comments

Tris Pharma, Inc., has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for a generic version of UCB's Tussionex, which is used for relief of cough and upper respiratory symptoms associated with allergy or a cold.

TOPICS:
Advertisement

Breakdown of Sanofi-Genzyme Deal

October 5, 2010 7:01 am | News | Comments

Here's how French pharmaceutical giant Sanofi-Aventis SA, which has initiated a hostile takeover attempt for Genzyme Corp. of Cambridge, Mass., describes how the proposed $18.5 billion deal would benefit the two companies and their shareholders.

TOPICS:

Merck Wants Fosamax Verdict Overturned

October 5, 2010 6:56 am | News | Comments

Merck & Co. says it will seek a new trial or even a ruling in its favor after a federal judge slashed the jury verdict against the drugmaker in the case of a woman alleging Merck's osteoporosis drug severely damaged her jaw.

TOPICS:

Gamma Radio HPLC Detector

October 4, 2010 8:24 am | Product Releases | Comments

LabLogic’s innovative Flow-RAM is a gamma radio HPLC detector specifically developed for PET and SPECT applications – the company’s response to five years’ feedback from customers in PET centres and nuclear medicine departments.

TOPICS:

Reference Dye

October 4, 2010 8:12 am | Product Releases | Comments

SsoFast EvaGreen Supermix with low ROX, now available from Bio-Rad Laboratories, Inc., enhances the speed, reliability, and sensitivity of qPCR experiments performed on instruments requiring ROX reference dye.

TOPICS:

Pharmatek Expands Manufacturing Capabilities

October 4, 2010 7:59 am | News | Comments

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added roller compaction to its solid oral dosage form manufacturing capabilities.

TOPICS:
Advertisement

Mallinckrodt Has Become Avantor

October 4, 2010 7:54 am | News | Comments

Mallinckrodt Baker will now be known as Avantor Performance Materials, company officials announced as they unveiled a new name and identity following the recent acquisition by an affiliate of New Mountain Capital.

TOPICS:

Immune Boost May Protect Newborns from AIDS

October 4, 2010 7:46 am | News | Comments

Researchers at Oregon Health & Science University may have uncovered a new weapon for combating HIV as it is passed from mother to newborn child.

TOPICS:

Heart-Lung Machine to Advance Safety Testing

October 4, 2010 7:42 am | News | Comments

Harvard bioengineers have been awarded more than $3 million in funding from the National Institutes of Health and the U.S. Food and Drug Administration to develop a "Heart-Lung Micromachine" that will accelerate drug safety and efficacy testing.

TOPICS:

CureVac Announces Data from Cancer Vaccine Trial

October 4, 2010 7:27 am | News | Comments

CureVac GmbH announced first data from an open-label phase 1/2a clinical trial of its mRNA vaccine CV9103 in patients with hormone-refractory prostate cancer with rising PSA and existing metastasis in the vast majority of patients.

TOPICS:

South Africa to Market Mood-Elevating Plant

October 4, 2010 7:20 am | by Jenny Gross | News | Comments

For hundreds of years, indigenous South Africans have chewed a plant they say reduces stress, relieves hunger, sedates and elevates moods. Now they have a license to study and market it, and plan to sell it over-the-counter worldwide.

TOPICS:

Pre-Existing Condition Insurance Plan Off to Rocky Start

October 4, 2010 7:03 am | by Ricardo Alonzo-Zaldivar | News | Comments

It's a centerpiece of President Barack Obama's health care remake, a lifeline available right now to vulnerable people whose medical problems have made them uninsurable.

TOPICS:

Sanofi Launches Hostile Takeover of Genzyme

October 4, 2010 7:01 am | by Greg Keller | News | Comments

France's Sanofi-Aventis launched an $18.5 billion hostile takeover offer for Genzyme Corp., stepping up its effort to capture the U.S. biotech company's promising drugs for high cholesterol and lucrative treatments for rare genetic disorders.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading